Table III.

The percentage of Alaska Native and American Indian persons with chronic hepatitis C virus (HCV) infection attending hepatology clinic scheduled appointments in 2003 and 2007, according to demographic and HCV infection characteristics

		2003		2007
Characteristic	Level	Attendance ratea	p-value	Attendance rate	p-value
Sex	Female	67% (34/51)	0.87	82% (61/74)	0.71
	Male	65% (28/43)		85% (61/72)
Age	<40 years	63% (19/30)	0.10	83% (25/30)	0.48
	40–49 years	56% (23/41)		88% (46/52)
	≥50 years	87% (20/23)		80% (51/64)
Time since diagnosis	<3 years	80% (20/25)	0.26	93% (40/43)	0.009
	3–7 years	59% (27/46)		86% (43/50)
	≥8 years	65% (15/23)		73% (38/52)
HCV genotype	1	61% (36/59)	0.41	81% (79/98)	0.15
	2	74% (14/19)		81% (17/21)
	3	75% (12/16)		99% (24/25)
ALT levelb	<40	62% (16/26)	0.34	85% (33/39)	0.79
	40 to <80	62% (21/34)		85% (50/59)
	≥80	73% (22/30)		87% (39/45)
Knodell fibrosis score	0–1	69% (22/32)	0.39	80% (41/51)	0.78
	3–4	82% (9/11)		83% (15/18)
HCV risk factor for infection	IVDUc	58% (35/60)	0.04e	80% (74/92)	0.17e
	BTd	80% (12/15)		86% (12/14)
	Other	78% (14/18)		90% (36/40)
Consume any alcohol	Yes	64% (28/44)	0.71	82% (55/67)	0.66
	No	67% (33/49)		85% (67/79)
History of >50 g/day of alcohol	Yes	67% (23/34)	0.79	88% (34/41)	0.38
	No	65% (39/60)		82% (86/105)

^aPercent of patients attending ≥1 appointment.

^bALT, alanine aminotransferase, in units/liter.

^cIVDU, intravenous drug use.

^dBT, blood transfusion.

^ep-value for IVDU vs. all others.